Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Cambridge Nutritional Sciences PLC (CNSL)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
3.25 -0.05    -1.52%
18/04 - Closed. Currency in GBP ( Disclaimer )
  • Volume: 152,847
  • Bid/Ask: 2.90 / 3.40
  • Day's Range: 3.20 - 3.30
Type:  Equity
Market:  United Kingdom
ISIN:  GB00B1VCP282 
SEDOL:  B1VCP28
Cambridge Nutritional Sciences 3.25 -0.05 -1.52%

LON:CNSL Financials

 
This summary provides an overview of the most significant critical numbers from each of the Omega financial reports, including theCambridge Nutritional Sciences PLC income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health.

Investors can select to view data from four periods of either annual or quarterly information, allowing them to track the LON:CNSL financials over time via breakdowns of their annual reports.

Cambridge Nutritional Sciences plc reported earnings results for the half year ended September 30, 2023. For the half year, the company reported sales was GBP 4.93 million compared to GBP 3.43 million a year ago. Net loss was GBP 0.698 million compared to GBP 2.09 million a year ago. Basic loss per share from continuing operations was GBP 0.003 compared to GBP 0.004 a year ago. Diluted loss per share from continuing operations was GBP 0.003 compared to GBP 0.004 a year ago. Basic loss per share was GBP 0.003 compared to GBP 0.009 a year ago. Diluted loss per share was GBP 0.003 compared to GBP 0.009 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

CNSL Income Statement & Profits

Gross margin TTM 52.9%
Operating margin TTM -25.11%
Net Profit margin TTM -27.32%
Return on Investment TTM -19.27%
 Total Revenue  Net Income
Period Ending: Mar 31, 2023 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Total Revenue 2.06 1.72 1.72
Gross Profit 0.846 0.926 0.926
Operating Income -1.03 -0.325 -0.325
Net Income -0.886 -1.04 -1.04

CNSL Balance Sheet

Quick Ratio MRQ 3.55
Current Ratio MRQ 4.12
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 2.3%
 Total Assets  Total Liabilities
Period Ending: Mar 31, 2023 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Total Assets 14.4 17.13 17.13 17.84
Total Liabilities 4.45 5.33 5.33 6.02
Total Equity 9.95 11.8 11.8 11.82

%ENGLISH_NAME% Latest Cash Flow Statement

Cash Flow/Share TTM -0.01
Revenue/Share TTM 0.04
Operating Cash Flow  -35.26%
 Cash  Net Change in Cash
Period Ending: Mar 31, 2023 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities -0.684 -0.892 -0.892
Cash From Investing Activities 1.97 0.62 0.62
Cash From Financing Activities -0.082 0.825 0.825
Net Change in Cash 1.2 0.554 0.554
* In Millions of GBP (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

CNSL Price Commentary

Write your thoughts about Cambridge Nutritional Sciences PLC
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
John Smith
John Smith Nov 24, 2022 11:39
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
£4m incoming, focus back on food intolerance business and targeting break even EBITDA by year end 👍🏻
Reply
3 0
Report
John Smith
John Smith Nov 16, 2022 10:39
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
A good recovery play. This traded around 8-10p before the Covid and gov contract madness.
Reply
2 0
Report
Duncan oatham
Duncan oatham Feb 20, 2022 1:39
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Glad I got stopped out at 95p
Reply
3 3
Report
Andrew Hess
Andrew Hess Feb 20, 2022 1:39
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
what a hero you are
Reply
0 0
Report
paul barnbrook
paul barnbrook Feb 10, 2022 16:07
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Here is a tip for you… look at the price of most pharma stocks before covid and thats whete they ate ahain now, or atlesdt heading that way. Full stop
Reply
3 0
Report
Jonny Tr
Jonny Tr Feb 10, 2022 16:07
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
yes pretty disappointing for investors! & revenues are pretty much the same as it was despite 2 years of massive tailwinds!!!
Reply
0 0
Report
Paul Wood
Paul Wood Feb 08, 2022 13:19
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
We definatly are not back🙈
Reply
0 2
Report
Nickesh Gadhvi
Nickesh Gadhvi Feb 03, 2022 8:02
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Finally we back
Reply
1 1
Report
Andy Hayden
Andy Hayden Feb 03, 2022 8:02
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
6 months too late.
Reply
0 0
Report
Nickesh Gadhvi
Nickesh Gadhvi Feb 03, 2022 8:02
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Let's see if we get some orders
Reply
0 0
Report
Andy Hayden
Andy Hayden Feb 01, 2022 16:17
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
lifestyle company completely incapable of growth. Competence level of middle managers (or lower) running a listed company.
Reply
1 0
Report
virg smit
virg smit Feb 01, 2022 9:29
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
The directors will soon be looking towards guarding their pay cheques so If they are going to raise money this current financia climate is not the best so the money vultures will be circlng for a heavy discount,larger than most expect with alllied dilution.Even then it will be difficult to look forward in business until the NHS mstter is fully dealt with.
Reply
0 0
Report
Andy Hayden
Andy Hayden Jan 31, 2022 17:33
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Amateurs. Utterly shambolic management.
Reply
0 0
Report
Aisha AbuShhewa
Aisha AbuShhewa Jan 19, 2022 8:01
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Here's to a new start, up and onwards.
Reply
2 5
Report
Kazi Ashraf
Kazi Ashraf Jan 19, 2022 8:01
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
What makes you so certain?
Reply
1 0
Report
Louise Lathwell
Louise Lathwell Jan 19, 2022 8:01
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Good joke
Reply
0 0
Report
Ayden Eesah
Ayden Eesah Jan 19, 2022 8:01
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Definitely a good joke after todays decline. LOK
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email